WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 382
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 612

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 10'787  10'518  10'268  10'034  9'807  7'385  6'322  6'090 
Births 471  461  453  445  438  357  302  257 
Surviving infants 436  426  417  409  402  322  263  223 
Pop. less than 5 years 1'971  1'933  1'910  1'891  1'862  1'469  1'181  1'076 
Pop. less than 15 years 5'038  4'933  4'843  4'760  4'672  3'484  2'837  2'662 
Female 15-49 years 2'396  2'325  2'256  2'191  2'131  1'614  1'433  1'399 

Number of reported cases

(Click for retrospective incidence data for Somalia)
Diphtheria
ChartChart
  65 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  7'497  10'229  3'173  9'983  17'298  3'965 
Mumps
ChartChart
 
Pertussis
ChartChart
  1'001  3'784  3'028 
Polio*
ChartChart
  195  96 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  182  224  233  966 
Tetanus (total)**
ChartChart
  321  233 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Somalia)
Vaccine year result method % card seen                                                
BCG          39  45  33  37  52  69 
DTP1          50  70  59  76  76  57 
DTP3          44  65  34  61  60  33 
DTP4         
IPV1         
HepB_BD         
HepB3          65  34 
Hib3          65  34 
JapEnc         
MCV1          41  70  29  49  79  16 
MCV2         
PCV1         
PCV3         
Pol3          42  66  24  47  49  37 
Rota1         
RotaC         
RCV1         
TT2plus 1999  22  MICS     67  30  24  52  47  22 
PAB         
VAD1          14  52  95 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Somalia)
BCG
ChartChart
  39  38  38  37  39  69  31 
DTP1
ChartChart
  52  52  52  52  52  57  42 
DTP3
ChartChart
  42  42  42  42  41  33  19 
HepB3
ChartChart
  42  42  42 
HepB_BD
ChartChart
 
Hib3
ChartChart
  42  42  42 
IPV1
ChartChart
 
MCV1
ChartChart
  46  46  46  46  46  24  30 
MCV2
ChartChart
 
PAB
ChartChart
  67  64  64  64  64  47  49 
PCV3
ChartChart
 
Pol3
ChartChart
  47  47  47  47  49  37  18 
RCV1
ChartChart
 
RotaC
ChartChart
 
YFV
ChartChart
 

Number of districts in the country 112  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
   
/
|
|
\
Greater or equal to 90% 22
From 80 to 89% 4
From 50 to 79% 11
Less than 50% 54
Proportion of districts
not reporting DTP3 coverage
9
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes pregnant women
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015    2011-2015  2011-2015  2011-2015  2011 -2015  2008 - 2010 
Nº of districts with microplans that include activities to raise immunization coverage number   10  15  89  40 

System performance

Total Nº districts in country number 112  99  99  20  20  98  113 
Nº districts with DTP3 coverage >=80% number 29  24  11  20 
% of districts with DTP3 coverage >=80% From 0 to 100% 26  24  11  30  20 
Nº districts with measles (MCV1) coverage >=95% number 17  12  16 
% of districts with MCV1 coverage >=95% From 0 to 100% 15  12  20  16 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No  No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%   NA  5-7% 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.